申请人:THE CLEVELAND CLINIC FOUNDATION
公开号:US09079854B2
公开(公告)日:2015-07-14
Hydrazone compounds which modulate cannabinoid receptors are presented. Pharmaceutical compositions containing these compounds, methods of using these compounds as modulators of cannabinoid receptors and processes for synthesizing these compounds are also described herein.
本文介绍了调节大麻素受体的腙类化合物。还描述了含有这些化合物的药物组合物,将这些化合物用作大麻素受体调节剂的方法以及合成这些化合物的过程。